NOVARTIS AG-REG's ticker is and the CUSIP is 7103065. A total of 4 filers reported holding NOVARTIS AG-REG in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $1,684,000 | +18.6% | 20,515 | +4.7% | 0.03% | +13.8% |
| Q1 2016 | $1,420,000 | -15.7% | 19,590 | +0.7% | 0.03% | -9.4% |
| Q4 2015 | $1,684,000 | +3.6% | 19,455 | +9.8% | 0.03% | -3.0% |
| Q3 2015 | $1,625,000 | -4.7% | 17,715 | +2.4% | 0.03% | +10.0% |
| Q2 2015 | $1,705,000 | +5.2% | 17,300 | +5.6% | 0.03% | +3.4% |
| Q1 2015 | $1,621,000 | +9.2% | 16,380 | +2.5% | 0.03% | +3.6% |
| Q4 2014 | $1,485,000 | -3.4% | 15,980 | -5.8% | 0.03% | 0.0% |
| Q2 2014 | $1,537,000 | – | 16,970 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boston Common Asset Management, LLC | 182,855 | $13,309,000 | 0.75% |
| Diversified Trust Co | 58,110 | $4,230,000 | 0.47% |
| Copeland Capital Management, LLC | 10,072 | $733,000 | 0.05% |
| Geneva Advisors, LLC | 19,590 | $1,420,000 | 0.03% |